Nanoparticles for immunotherapy
US8021689B2 · kind B2 · utility
29Cited by
9References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2007 |
| Grant date | Sep 20, 2011 |
| Priority date | — |
| Expiry date | Dec 7, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6093
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nanoparticles that activate complement in the absence of biological molecules are described. The nanoparticles are shown to specifically target antigen presenting cells in specifically in lymph nodes, without the use of a biological molecule for targeting. These particles are useful vehicles for delivering immunotherapeutics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.